Invention Grant
US08455504B2 Inhibition of the activity of the capsaicin receptor in the treatment of type 1 diabetes, type 2 diabetes, impaired glucose tolerance or insulin resistance
有权
抑制辣椒素受体在治疗1型糖尿病，2型糖尿病，葡萄糖耐量降低或胰岛素抵抗方面的活性
- Patent Title: Inhibition of the activity of the capsaicin receptor in the treatment of type 1 diabetes, type 2 diabetes, impaired glucose tolerance or insulin resistance
- Patent Title (中): 抑制辣椒素受体在治疗1型糖尿病，2型糖尿病，葡萄糖耐量降低或胰岛素抵抗方面的活性
-
Application No.: US12976057Application Date: 2010-12-22
-
Publication No.: US08455504B2Publication Date: 2013-06-04
- Inventor: Dorte Xenia Gram , Anker Jon Hansen
- Applicant: Dorte Xenia Gram , Anker Jon Hansen
- Applicant Address: DK
- Assignee: Xenia Pharma
- Current Assignee: Xenia Pharma
- Current Assignee Address: DK
- Agency: Woodcock Washburn LLP
- Priority: DK200401126 20040719
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K31/517 ; A61K31/50
Abstract:
The present invention provides a method of treating diseases or disorders benefiting from inactivating or down-regulating the activity of the capsaicin receptor in a mammal by inhibiting the activity of the capsaicin receptor. The present invention also provides a method of treating obesity and obesity-related diseases and disorders in a mammal by inhibiting the activity of the capsaicin receptor.
Public/Granted literature
Information query
IPC分类:
